ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,173,689 | +13.3% | 60,973 | +46.6% | 0.00% | 0.0% |
| Q2 2023 | $1,918,085 | +14.8% | 41,580 | -0.2% | 0.00% | – |
| Q1 2023 | $1,670,326 | +242.4% | 41,654 | +295.6% | 0.00% | – |
| Q4 2022 | $487,855 | +46.5% | 10,530 | +30.8% | 0.00% | – |
| Q3 2022 | $333,000 | -50.8% | 8,048 | -29.1% | 0.00% | – |
| Q2 2022 | $677,000 | +70.1% | 11,345 | +106.9% | 0.00% | – |
| Q1 2022 | $398,000 | +41.1% | 5,484 | +63.6% | 0.00% | – |
| Q4 2021 | $282,000 | -43.6% | 3,352 | -39.6% | 0.00% | – |
| Q3 2021 | $500,000 | -90.9% | 5,548 | -90.3% | 0.00% | -100.0% |
| Q2 2021 | $5,477,000 | -34.9% | 57,433 | -22.2% | 0.00% | -50.0% |
| Q1 2021 | $8,410,000 | -28.2% | 73,866 | -12.7% | 0.00% | -33.3% |
| Q4 2020 | $11,717,000 | +245.6% | 84,643 | +105.2% | 0.00% | +200.0% |
| Q3 2020 | $3,390,000 | -26.6% | 41,239 | -30.1% | 0.00% | 0.0% |
| Q2 2020 | $4,617,000 | +197.5% | 59,014 | +68.9% | 0.00% | 0.0% |
| Q1 2020 | $1,552,000 | -28.7% | 34,939 | -31.4% | 0.00% | 0.0% |
| Q4 2019 | $2,177,000 | +31.9% | 50,954 | +32.0% | 0.00% | – |
| Q3 2019 | $1,651,000 | -68.2% | 38,606 | -75.3% | 0.00% | -100.0% |
| Q2 2019 | $5,185,000 | -8.0% | 156,189 | +92.1% | 0.00% | -50.0% |
| Q1 2019 | $5,638,000 | +401.2% | 81,286 | +214.1% | 0.00% | – |
| Q4 2018 | $1,125,000 | -37.9% | 25,881 | +9.0% | 0.00% | -100.0% |
| Q3 2018 | $1,812,000 | +4.5% | 23,742 | +5.3% | 0.00% | 0.0% |
| Q2 2018 | $1,734,000 | +40.5% | 22,548 | -6.8% | 0.00% | – |
| Q1 2018 | $1,234,000 | +15.4% | 24,200 | +5.0% | 0.00% | – |
| Q4 2017 | $1,069,000 | -57.1% | 23,051 | -50.8% | 0.00% | -100.0% |
| Q3 2017 | $2,494,000 | -84.6% | 46,844 | -82.0% | 0.00% | -80.0% |
| Q2 2017 | $16,193,000 | -57.5% | 260,708 | -53.6% | 0.01% | -58.3% |
| Q1 2017 | $38,118,000 | -29.1% | 562,390 | -26.5% | 0.01% | -36.8% |
| Q4 2016 | $53,766,000 | +3.0% | 764,694 | +3.9% | 0.02% | 0.0% |
| Q3 2016 | $52,197,000 | -20.8% | 735,807 | -45.4% | 0.02% | -26.9% |
| Q2 2016 | $65,939,000 | -39.8% | 1,348,155 | -22.0% | 0.03% | -40.9% |
| Q1 2016 | $109,461,000 | -45.0% | 1,728,962 | -2.6% | 0.04% | -44.3% |
| Q4 2015 | $199,090,000 | +32.9% | 1,774,736 | +14.1% | 0.08% | +25.4% |
| Q3 2015 | $149,761,000 | +76.5% | 1,554,990 | +87.7% | 0.06% | +90.9% |
| Q2 2015 | $84,835,000 | +6047.5% | 828,545 | +3631.8% | 0.03% | – |
| Q1 2015 | $1,380,000 | +1337.5% | 22,202 | +906.4% | 0.00% | – |
| Q4 2014 | $96,000 | +174.3% | 2,206 | +255.2% | 0.00% | – |
| Q3 2014 | $35,000 | -5.4% | 621 | -25.5% | 0.00% | – |
| Q2 2014 | $37,000 | +76.2% | 834 | +95.8% | 0.00% | – |
| Q1 2014 | $21,000 | – | 426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |